Cargando…
Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial
BACKGROUND: There is evidence supporting the use of extracorporeal shock wave therapy (ESWT) in calcific tendinopathy of the rotator cuff, but the best current evidence does not support its use in non-calcifying tendinopathy. We conducted a randomized placebo-controlled trial to investigate the effi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434084/ https://www.ncbi.nlm.nih.gov/pubmed/22672772 http://dx.doi.org/10.1186/1471-2474-13-86 |
_version_ | 1782242388939374592 |
---|---|
author | Galasso, Olimpio Amelio, Ernesto Riccelli, Daria Anna Gasparini, Giorgio |
author_facet | Galasso, Olimpio Amelio, Ernesto Riccelli, Daria Anna Gasparini, Giorgio |
author_sort | Galasso, Olimpio |
collection | PubMed |
description | BACKGROUND: There is evidence supporting the use of extracorporeal shock wave therapy (ESWT) in calcific tendinopathy of the rotator cuff, but the best current evidence does not support its use in non-calcifying tendinopathy. We conducted a randomized placebo-controlled trial to investigate the efficacy and safety of low energy ESWT for non-calcifying tendinopathy of the rotator cuff. METHODS: 20 patients with non-calcifying supraspinatus tendinopathy (NCST) were randomized to an active or a sham treatment group. Physical, blood, roentgenographic, and MRI examinations of the shoulder were conducted to verify that patients met the inclusion and exclusion criteria. These examinations were repeated six and twelve weeks after treatments. Effectiveness was determined by comparison of the mean improvement in the Constant and Murley score (CMS) between the treatment and the placebo groups at three months. Safety was assessed by analyzing the number and severity of adverse events. RESULTS: All the patients completed the investigation protocol. At the final follow-up, significant improvement in the total CMS score and most of the CMS subscales was observed in the ESWT group when compared to the baseline values. Significantly higher total CMS, and significantly higher scores for CMS pain and ROM were observed in the ESWT group when compared to the placebo. No serious adverse events were noted after ESWT. CONCLUSIONS: Patients suffering from NCST may benefit from low energy ESWT, at least in short-term. The application protocol of ESWT is likely to play a key-role in a successful treatment. Future investigations should be undertaken on the long-term effects of this technique for the treatment of NCST. TRIAL REGISTRATION: Current Controlled Trials ISRCTN41236511 |
format | Online Article Text |
id | pubmed-3434084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34340842012-09-06 Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial Galasso, Olimpio Amelio, Ernesto Riccelli, Daria Anna Gasparini, Giorgio BMC Musculoskelet Disord Research Article BACKGROUND: There is evidence supporting the use of extracorporeal shock wave therapy (ESWT) in calcific tendinopathy of the rotator cuff, but the best current evidence does not support its use in non-calcifying tendinopathy. We conducted a randomized placebo-controlled trial to investigate the efficacy and safety of low energy ESWT for non-calcifying tendinopathy of the rotator cuff. METHODS: 20 patients with non-calcifying supraspinatus tendinopathy (NCST) were randomized to an active or a sham treatment group. Physical, blood, roentgenographic, and MRI examinations of the shoulder were conducted to verify that patients met the inclusion and exclusion criteria. These examinations were repeated six and twelve weeks after treatments. Effectiveness was determined by comparison of the mean improvement in the Constant and Murley score (CMS) between the treatment and the placebo groups at three months. Safety was assessed by analyzing the number and severity of adverse events. RESULTS: All the patients completed the investigation protocol. At the final follow-up, significant improvement in the total CMS score and most of the CMS subscales was observed in the ESWT group when compared to the baseline values. Significantly higher total CMS, and significantly higher scores for CMS pain and ROM were observed in the ESWT group when compared to the placebo. No serious adverse events were noted after ESWT. CONCLUSIONS: Patients suffering from NCST may benefit from low energy ESWT, at least in short-term. The application protocol of ESWT is likely to play a key-role in a successful treatment. Future investigations should be undertaken on the long-term effects of this technique for the treatment of NCST. TRIAL REGISTRATION: Current Controlled Trials ISRCTN41236511 BioMed Central 2012-06-06 /pmc/articles/PMC3434084/ /pubmed/22672772 http://dx.doi.org/10.1186/1471-2474-13-86 Text en Copyright ©2012 Galasso et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Galasso, Olimpio Amelio, Ernesto Riccelli, Daria Anna Gasparini, Giorgio Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial |
title | Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial |
title_full | Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial |
title_fullStr | Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial |
title_full_unstemmed | Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial |
title_short | Short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial |
title_sort | short-term outcomes of extracorporeal shock wave therapy for the treatment of chronic non-calcific tendinopathy of the supraspinatus: a double-blind, randomized, placebo-controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434084/ https://www.ncbi.nlm.nih.gov/pubmed/22672772 http://dx.doi.org/10.1186/1471-2474-13-86 |
work_keys_str_mv | AT galassoolimpio shorttermoutcomesofextracorporealshockwavetherapyforthetreatmentofchronicnoncalcifictendinopathyofthesupraspinatusadoubleblindrandomizedplacebocontrolledtrial AT amelioernesto shorttermoutcomesofextracorporealshockwavetherapyforthetreatmentofchronicnoncalcifictendinopathyofthesupraspinatusadoubleblindrandomizedplacebocontrolledtrial AT riccellidariaanna shorttermoutcomesofextracorporealshockwavetherapyforthetreatmentofchronicnoncalcifictendinopathyofthesupraspinatusadoubleblindrandomizedplacebocontrolledtrial AT gasparinigiorgio shorttermoutcomesofextracorporealshockwavetherapyforthetreatmentofchronicnoncalcifictendinopathyofthesupraspinatusadoubleblindrandomizedplacebocontrolledtrial |